Leslie Olmedo Nieva

Ms. Leslie Olmedo Nieva

Instituto Nacional de Cancerología, Tlalpan, Mexico

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2015 in Viruses
Verified
Journal Article
Open access
PDF file
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
LNLeslie Olmedo Nieva
Leslie Olmedo Nieva
ACAdriana Contreras
Adriana Contreras
AGAlma Mariana Fuentes Gonzalez
Alma Mariana Fuentes Gonzalez
LRLeticia Rocha-Zavaleta
Leticia Rocha-Zavaleta
MLMarcela Lizano
Marcela Lizano
Cell signaling pathways are the mechanisms by which cells transduce external stimuli, which control the transcription of genes, to regulate diverse biological effects. In cancer, distinct signaling pathways, such as the Wnt/β-catenin pathway, have been implicated in the deregulation of critical molecular processes that affect cell proliferation and differentiation. For example, changes in β-catenin localization have been identified in Human Papillomavirus (HPV)-related cancers as the lesion progresses. Specifically, β-catenin relocates from the membrane/cytoplasm to the nucleus, suggesting that this transcription regulator participates in cervical carcinogenesis. The E6 and E7 oncoproteins are responsible for the transforming activity of HPV, and some studies have implicated these viral oncoproteins in the regulation of the Wnt/β-catenin pathway. Nevertheless, new interactions of HPV oncoproteins with cellular proteins are emerging, and the study of the biological effects of such interactions will help to understand HPV-related carcinogenesis. Viruses 2015, 7 4735 This review addresses the accumulated evidence of the involvement of the HPV E6 and E7 oncoproteins in the activation of the Wnt/β-catenin pathway.

18 January 2018 in Viruses
Verified
Journal Article
Open access
PDF file
LNLeslie Olmedo Nieva
Leslie Olmedo Nieva
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
ACAdriana Contreras
Adriana Contreras
MLMarcela Lizano
Marcela Lizano
Persistent infections with High Risk Human Papillomaviruses (HR-HPVs) are the main cause of cervical cancer development. The E6 and E7 oncoproteins of HR-HPVs are derived from a polycistronic pre-mRNA transcribed from an HPV early promoter. Through alternative splicing, this pre-mRNA produces a variety of E6 spliced transcripts termed E6*. In pre-malignant lesions and HPV-related cancers, different E6/E6* transcriptional patterns have been found, although they have not been clearly associated to cancer development. Moreover, there is a controversy about the participation of E6* proteins in cancer progression. This review addresses the regulation of E6 splicing and the different functions that have been found for E6* proteins, as well as their possible role in HPV-induced carcinogenesis.

Verified
Journal Article
Open access
PDF file
YOYunuen Ortiz-Pedraza
Yunuen Ortiz-Pedraza
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
LNLeslie Olmedo Nieva
Leslie Olmedo Nieva
ACAdriana Contreras
Adriana Contreras
IRImelda Martínez Ramírez
Imelda Martínez Ramírez
MLMarcela Lizano
Marcela Lizano
Cancer cells exhibit exacerbated metabolic activity to maintain their accelerated proliferation and microenvironmental adaptation in order to survive under nutrient-deficient conditions. Tumors display an increase in glycolysis, glutaminolysis and fatty acid biosynthesis, which provide their energy source. Glutamine is critical for fundamental cellular processes, where intermediate metabolites produced through glutaminolysis are necessary for the maintenance of mitochondrial metabolism. These include antioxidants to remove reactive oxygen species, and the generation of the nonessential amino acids, purines, pyrimidines and fatty acids required for cellular replication and the activation of cell signaling. Some cancer cells are highly dependent on glutamine consumption since its catabolism provides an anaplerotic pathway to feed the Krebs cycle. Intermediate members of the glutaminolysis pathway have been found to be deregulated in several types of cancers and have been proposed as therapeutic targets and prognostic biomarkers. This review summarizes the main players in the glutaminolysis pathway, how they have been found to be deregulated in cancer and their implications for cancer maintenance. Furthermore, non-coding RNAs are now recognized as new participants in the regulation of glutaminolysis; therefore, their involvement in glutamine metabolism in cancer is discussed in detail.

Verified
Journal Article
Open access
PDF file
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
LNLeslie Olmedo Nieva
Leslie Olmedo Nieva
LCLeonardo Josué Castro-Muñoz
Leonardo Josué Castro-Muñoz
JMJoaquin Manzo-Merino
Joaquin Manzo-Merino
ACAdriana Contreras
Adriana Contreras
MLMarcela Lizano
Marcela Lizano
The Wnt/β-catenin signaling pathway regulates cell proliferation and differentiation and its aberrant activation in cervical cancer has been described. Persistent infection with high risk human papillomavirus (HR-HPV) is the most important factor for the development of this neoplasia, since E6 and E7 viral oncoproteins alter cellular processes, promoting cervical cancer development. A role of HPV-16 E6 in Wnt/β-catenin signaling has been proposed, although the participation of HPV-18 E6 has not been previously studied. The aim of this work was to investigate the participation of HPV-18 E6 and E6*I, in the regulation of the Wnt/β-catenin signaling pathway. Here, we show that E6 proteins up-regulate TCF-4 transcriptional activity and promote overexpression of Wnt target genes. In addition, it was demonstrated that E6 and E6*I bind to the TCF-4 (T cell factor 4) and β-catenin, impacting TCF-4 stabilization. We found that both E6 and E6*I proteins interact with the promoter of Sp5, in vitro and in vivo. Moreover, although differences in TCF-4 transcriptional activation were found among E6 intratype variants, no changes were observed in the levels of regulated genes. Furthermore, our data support that E6 proteins cooperate with β-catenin to promote cell proliferation.

24 January 2023 in Viruses
Verified
Journal Article
Open access
PDF file
YOYunuen Ortiz-Pedraza
Yunuen Ortiz-Pedraza
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
LRLucio Antonio Ramos-Chávez
Lucio Antonio Ramos-Chávez
IRImelda Martínez Ramírez
Imelda Martínez Ramírez
LNLeslie Olmedo Nieva
Leslie Olmedo Nieva
MLMarcela Lizano
Marcela Lizano
Persistent high-risk human papillomavirus infection is the main risk factor for cervical cancer establishment, where the viral oncogenes E6 and E7 promote a cancerous phenotype. Metabolic reprogramming in cancer involves alterations in glutamine metabolism, also named glutaminolysis, to provide energy for supporting cancer processes including migration, proliferation, and production of reactive oxygen species, among others. The aim of this work was to analyze the effect of HPV16 E6 and E7 oncoproteins on the regulation of glutaminolysis and its contribution to cell proliferation. We found that the E6 and E7 oncoproteins exacerbate cell proliferation in a glutamine-dependent manner. Both oncoproteins increased the levels of transporter SNAT1, as well as GLS2 and GS enzymes; E6 also increased LAT1 transporter protein levels, while E7 increased ASCT2 and xCT. Some of these alterations are also regulated at a transcriptional level. Consistently, the amount of SNAT1 protein decreased in Ca Ski cells when E6 and E7 expression was knocked down. In addition, we demonstrated that cell proliferation was partially dependent on SNAT1 in the presence of glutamine. Interestingly, SNAT1 expression was higher in cervical cancer compared with normal cervical cells. The high expression of SNAT1 was associated with poor overall survival of cervical cancer patients. Our results indicate that HPV oncoproteins exacerbate glutaminolysis supporting the malignant phenotype.

6 December 2022 in Cells
Verified
Journal Article
Open access
PDF file
LNLeslie Olmedo Nieva
Leslie Olmedo Nieva
J. Omar Muñoz-BelloJ. Omar Muñoz-Bello
J. Omar Muñoz-Bello
IRImelda Martínez Ramírez
Imelda Martínez Ramírez
AGAntonio Martinez Gutierrez
Antonio Martinez Gutierrez
YOYunuen Ortiz-Pedraza
Yunuen Ortiz-Pedraza
MLMarcela Lizano
Marcela Lizano
High-risk human papillomavirus (HPV) infection is the main risk factor for cervical cancer (CC) development, where the continuous expression of E6 and E7 oncoproteins maintain the malignant phenotype. In Mexico, around 70% of CC cases are diagnosed in advanced stages, impacting the survival of patients. The aim of this work was to identify biomarkers affected by HPV-16 E6 and E7 oncoproteins that impact the prognosis of CC patients. Expression profiles dependent on E6 and E7 oncoproteins, as well as their relationship with biological processes and cellular signaling pathways, were analyzed in CC cells. A comparison among expression profiles of E6- and E7-expressing cells and that from a CC cohort obtained from The Cancer Genome Atlas (TCGA) demonstrated that the expression of 13 genes impacts the overall survival (OS). A multivariate analysis revealed that the downregulated expression of RIPOR2 was strongly associated with a worse OS. RIPOR2, including its transcriptional variants, were overwhelmingly depleted in E6- and E7-expressing cells. Finally, in a Mexican cohort, it was found that in premalignant cervical lesions, RIPOR2 expression decreases as the lesions progress; meanwhile, decreased RIPOR2 expression was also associated with a worse OS in CC patients.